Gyeonggi, South Korea

SeoRyong Kwak

This inventor holds 2 USPTO granted patents. Top assignee: Siemens Medical Solutions USA, Inc.. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: SeoRyong Kwak. Retrieved from https://idiyas.com/inventor/seoryong-kwak

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.8

ph-index = 2

Forward Citations = 18(Granted Patents)


Location History:

  • Gyeonggi, KR (2019)
  • Gyeonggi-do, KR (2019)

Company Filing History:


Years Active: 2019

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of SeoRyong Kwak

Introduction

SeoRyong Kwak is a notable inventor based in Gyeonggi, South Korea. He has made significant contributions to the field of medical technology, particularly in ultrasound diagnostics. With a total of 2 patents to his name, his work has had a meaningful impact on healthcare.

Latest Patents

SeoRyong Kwak's latest patent is an ultrasound diagnostic apparatus. This innovative device enhances the capabilities of ultrasound technology, providing better diagnostic tools for medical professionals.

Career Highlights

He is currently employed at Siemens Medical Solutions USA, Inc., where he continues to develop advanced medical technologies. His work at Siemens has allowed him to collaborate with leading experts in the field.

Collaborations

Some of his notable coworkers include JooYeon Lee and DeaKi Hong. Together, they contribute to the advancement of medical technology and innovation.

Conclusion

SeoRyong Kwak's contributions to ultrasound diagnostics exemplify the importance of innovation in healthcare. His work continues to influence the medical field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…